Literature DB >> 8869877

Cardioprotective effects of ovarian hormones.

G M Rosano1, S L Chierchia, F Leonardo, C M Beale, P Collins.   

Abstract

This paper reviews the evidence regarding the cardioprotective effects of oestrogen replacement therapy in postmenopausal women. Oestrogens have been shown to improve serum lipid profiles, carbohydrate metabolism, and insulin sensitivity; prevent the formation and development of atherosclerotic plaque; reduce blood pressure and plasma fibrinogen levels; and favourably affect overall cardiac function. Thus, oestrogen replacement therapy may prevent or inhibit the progression of existing coronary disease, and may also have a protective effect against acute cardiovascular and cerebrovascular ischaemic events.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8869877     DOI: 10.1093/eurheartj/17.suppl_d.15

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  4 in total

Review 1.  Putting the cardiovascular safety of aromatase inhibitors in patients with early breast cancer into perspective: a systematic review of the literature.

Authors:  Muhammad Younus; Michelle Kissner; Lester Reich; Nicola Wallis
Journal:  Drug Saf       Date:  2011-12-01       Impact factor: 5.606

2.  Acute coronary syndrome in young adults from a Malaysian tertiary care centre.

Authors:  Fan Kee Hoo; Yoke Loong Foo; Sazlyna Mohd Sazlly Lim; Siew Mooi Ching; Yang Liang Boo
Journal:  Pak J Med Sci       Date:  2016 Jul-Aug       Impact factor: 1.088

Review 3.  Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer.

Authors:  Stefano Gonnelli; Roberto Petrioli
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

4.  Musa balbisiana Fruit Rich in Polyphenols Attenuates Isoproterenol-Induced Cardiac Hypertrophy in Rats via Inhibition of Inflammation and Oxidative Stress.

Authors:  Sima Kumari; Parmeshwar B Katare; R Elancheran; Hina L Nizami; Bugga Paramesha; Sudheer Arava; Partha Pratim Sarma; Roshan Kumar; Dinesh Mahajan; Yashwant Kumar; Rajlakshmi Devi; Sanjay K Banerjee
Journal:  Oxid Med Cell Longev       Date:  2020-01-27       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.